JOHN RATEY M.D.
Curriculum Vitae
NAME: John Joseph Ratey, M.D.
ADDRESS: 328 Broadway, Cambridge, MA 02139
PLACE OF BIRTH: Rochester, Pennsylvania
EDUCATION:
1966-70 A.B., Philosophy, Colgate University, Hamilton, NY.
1970-72 Premedical Sciences, Northeastern University, Harvard University, Boston University,
Boston College, Boston, MA.
1972-76 M.D., University of Pittsburgh School of Medicine,
Pittsburgh, PA.
1973-76 Personal Psychoanalysis, Pittsburg Psychoanalytic Center, Pittsburgh, PA.
POSTDOCTORAL TRAINING:
1976-77 Rotating internship in Neurology, St. Francis General Hospital, Pittsburgh, PA.
1977-80 Psychiatric Residency, Massachusetts Mental Health Center, Boston, MA.
1979-80 Chief Resident, Inpatient Service, Massachusetts Mental Health Center, Boston, MA.
1978-79 Clinical Fellow, Chronic Care Program, Harvard Medical School, Boston, MA.
1978-80 Falk Fellowship, American Psychiatric Association.
1980-81 Elvin Semrad Teaching Fellowship, Massachusetts Mental Health Center.
LICENSE AND CERTIFICATION:
1977 Massachusetts Medical License
1984 American Board of Psychiatry and Neurology
2010 California Medical License
ACADEMIC APPOINTMENTS:
1980-81 Assistant Clinical Professor of Psychiatry, Tufts Medical School, Boston, MA.
1980-86 Instructor in Psychiatry, Harvard Medical School, Boston, MA.
1982-88 Assistant Director of Residency Training, Massachusetts Mental Health Center, Boston, MA.
1986-92 Assistant Professor of Psychiatry, Harvard Medical School, Boston, MA.
1992- Associate Clinical Professory of Psychiatry, Harvard Medical School, Boston, MA.
2011 Adjunct Professor of Sports Science, National Taiwan State University
HOSPITAL APPOINTMENTS:
1970-71 Psychiatric Attendant, Massachusetts Mental Health Center Boston, MA.
1979-80 Consultant, Metropolitan State Hospital, Waltham, MA.
1979-81 Consultant, Dorchester Unit, Boston City Hospital, Boston, MA.
1979-92 Consultant, Danvers State Hospital, Danvers, MA.
1980-89 Consultant, Medfield State Hospital, Medfield, MA.
1986-89 Clinical Director, Developmental Disabilities Unit, Medfield State Hospital, Medfield, MA.
1986-99 Director of Research, Medfield State Hospital, Medfield, MA
1989-91 Acting Executive Medical Director, Medfield State Hospital, Medfield, MA.
1990-91 Consultant, Wyoming State Hospital, Evanston, WY.
ADDITIONAL PROFESSIONAL POSITIONS:
1971-72 Halfway House Parent, DARE, Inc., Boston, MA.
1978-80 Consultant, City of Boston Methadone Maintenance Program, Boston, MA.
1978-82 Chief Psychiatrist, Clinton Child and Family Center, Clinton, MA.
1978-99 Director, New England Psychiatric Consultants, P.C.
1979-92 Consultant, Hogan Regional Center, Danvers, MA.
1985-88 Consultant, CAMARY Corporation, Albany, NY.
1988-89 Consultant, Wheat Ridge Developmental Center, Wheat Ridge, CO
1990-92 Consultant, Colorado Longitudinal Studies of First Break Psychoses, Denver, CO
1990-91 Consultant, Sonoma Developmental Center, Sonoma, CA.
1990-91 Consultant, University of Colorado, CO.
2010- Board Member, Sparkinglife, a 501C3 corporation
2011- Consultant to the California’s Governor’s Council on Physical Fitness and Sport
2012- Consultant to the State of Utah House of Representatives
AWARDS AND HONORS:
1968-70 Washburn Scholar, Colgate University, Hamilton, NY.
1975 American Heart Association, Pennsylvania Affiliate Undergraduate Research Prize at the University of Pittsburgh School of Medicine,
for the manuscript: An investigation into the etiology of hypertension of neonatal populations.
1975-76 Rock Sylvester Memorial Scholarship, American Medical Association.
1976 L.W. Earley, M.D. Memorial Prize for the Highest Scholastic Performance in Psychiatry at the University of Pittsburgh.
1976 Joseph Heidenkamp Child Psychiatry Award at the University of Pittsburgh School of Medicine for the Highest Scholastic Performance in
Child Psychiatry.
1985 Harry C. Solomon Award.
1988 Guest lecturer, Psychopharmacology of Aggression, Colloquium Internationale Neuro-Psychopharmacologicum, Munich, Germany.
1999 Elected to the Adult Attention Deficit Disorder Hall of Fame
2000 Guest Lecturer, Professor of the Day, Colgate University
1996-2013 Awarded Best Doctor in America Designation.
2006 Awarded PE4LIFE’s National Excellence in Advocacy Award
2008 Harman Lectureship University of Nebraska School of Medicine
2008 Karpovich Lectureship Springfield College
2010- Reebok’s Ambassador for Active Kids
2011 Eagle Hill Pioneer Award
2012 Member of the South Korean Brain Institute’s Initial Conference- Daegu, South Korea
MAJOR COMMITTEE ASSIGNMENTS:
National
1985 APA symposium: The Use of Beta-Blockers to Treat Aggression, Chairperson, American Psychiatric Association.
1986 APA symposium: The Obsolescence of Neuroleptics, Co-Chairperson, American Psychiatric Association.
1989 APA symposium: New Developments in Treatment of the Dually-Diagnosed, Chairperson, American Psychiatric Association.
1990 APA symposium: Paying Attention to Attention in Adult Psychiatry, Chairperson, American Psychiatric Association.
1991 APA symposium: The use of serotonergic agents to treat aggression, Chairperson, American Psychiatric Association.
1993 APA symposium: Assessment and Treatment of Attention Deficit Disorder in Adults, Chairperson, American Psychiatric Association.
Regional
1985 Award Committee for the Placement of Autistic Adults, Panel Member, Massachusetts Department of Mental Retardation.
1986 National panel of experts evaluating the use of aversive therapies at the Behavior Research Institute, Providence, RI, Member, Massachusetts Department of Mental Retardation.
1990 Founder and Developer, Clinical Aggression Research Group.
MEMBERSHIPS, OFFICES AND COMMITTEE ASSIGNMENTS IN PROFESSIONAL SOCIETIES:
1977- American Psychiatric Association.
1978-80 Council on Research and Development, American Psychiatric Association.
1979-80 Chairperson, Committee for Residents, Massachusetts Psychiatric Association.
1986 Founder/Member Steering Committee, Boston Center for the Study of Autism.
1986-91 Scientific Associate, American Academy of Psychoanalysis.
1992-96 Advisory Board, CHADD
EDITORIAL BOARDS:
1995 - Editorial Board of Primary Psychiatry
1997 - Editorial Board of Mental Fitness
MAJOR RESEARCH INTERESTS:
1. Clinical effectiveness of beta-blockers and serotonin active agents.
2. Theoretical aspects of aggression and affect tolerance.
3. Neuropsychiatry of developmental disabilities.
4. Adult Attention Deficit Disorder: Identification and Treatment.
5. Effect of Exercise and Play on School Children
6. Effect of Exercise on Adults and People with Special Abilities
RESEARCH FUNDING INFORMATION:
1972-75 Co-Investigator with Joseph Schachter, M.D., Ph.D., Pittsburgh, PA. Psychophysiological characteristics of offspring of schizophrenic mothers and
neonatal cardiovascular characteristics of black and white races.
1976 Co-Investigator with Alan Mallinger, M.D., and Israel Hanin, Ph.D., Pittsburgh, PA. Kinetics of the red cell membrane and lithium transport.
1978-79 Co-Investigator with Alan Hobson, M.D., and Ennio Vivaldi, M.D., Boston, MA. Neuroanatomical centers for the control of REM sleep.
1984-86 Co-Investigator with Miles Shore, M.D., grant from the National Institute of Mental Health, Training for Leadership in Public Psychiatry Program.
1984-88 Principal Investigator, grant from E.R. Squibb & Co. The use of nadolol to control aggressive and impulsive behaviors.
1985 Member, Scientific Advisory Council, E.R. Squibb & Co.
1986-88 Principal Investigator, E. R. Squibb & Co. The use of nadolol in autistic adults to control aggressive and self-injurious behaviors.
1987-88 Principal Investigator, grant from Sandoz Pharmaceuticals. Comparative double-blind study of pindolol vs. placebo in the treatment of aggressive
behaviors in mental retardation.
1988 Principal Investigator, State of California. Use of nadolol to control violence in chronically aggressive patients.
1988 Principal Investigator, Mead Johnson Pharmaceuticals. Use of buspirone in outpatients with mental retardation and aggression.
1990-92 Principal Investigator, Solvay-Duphar Pharmaceuticals. Eltoprazine treatment of the mentally retarded with destructive behavior.
1993 Principal Investigator, Abbott Laboratories. A double-blind, placebo-controlled, Haldol-referenced study of the safety and efficacy of sertindole in
schizophrenic patients.
1993 Principal Investigator, Lilly Research Laboratories. Olanzapine versus haloperidol in the treatment of schizophrenia and other psychiatric
disorders.
2011 Principal Investigator Eagle Hill School, Effect of Exercise Pre-school on children with learning differences
2011 Principal Investigator, Microsoft, on the use of XBOX in the classroom to improve focus and concentration
2012 Principal Investigator, Specialized Bicycles, effect of pre-school Bicycle riding on a 5th grade population with ADHD.
2012 Principal Investigator, Landmark East School, Wolfville, NS, effect on adding multiple periods of exercise on children with assorted learning
differences.
PRINCIPAL CLINICAL AND HOSPITAL SERVICE RESPONSIBILITIES:
1986-89 Clinical Director, Developmental Disabilities Unit, Medfield State Hospital, Medfield, MA.
1986-99 Director of Research, Medfield State Hospital, Medfield, MA
1978-82 Chief Psychiatrist, Clinton Child and Family Center, Clinton, MA.
MAJOR ADMINISTRATIVE RESPONSIBILITIES:
1989-91 Acting Executive Medical Director, Medfield State Hospital, Medfield, MA.
1978-99 Director, New England Psychiatric Consultants, P.C.
2010- Board Member Sparkinglife
SELF REPORT OF TEACHING:
Common Lecture topics:
- understanding and treatment of the aggressive patient,
- recognition and coping strategies for living with Attention Deficit Disorder
- psychopharmacology for aggression, ADD, autism, and other mental disorders
- understanding mild forms of neuropsychiatric disorders
- effect of exercise on emotional regulation and optimizing cognition in all age groups
- effect of exercise on children and their schools
- use of exergaming as a means to get people moving
1. Local Contribution
a. Medical School courses:
1983-88 Participant in organization of the residency training program and didactic curriculum, Massachusetts Mental Health Center.
1990- Lecturer at McLean Hospital, Psychopharmacology Residency Program.
1991 Examiner for Psychiatry Boards Course, Continuing Medical Education, six times per year, Massachusetts Mental Health Center.
1994- Lecturer for week long summer series on Cape Cod for Massachusetts Mental Health Center.
1994 Lecturer for Brain Behavior Series three times per year on Attention Deficit Disorder.
b. Hospital courses and invited teaching presentations:
1986-89 Lectured by invitation at 14 hospitals on a variety of above topics.
1990 - Ongoing invitations to lecture at Grand Rounds, McLean Hospital, Belmont, MA.
1990 - Lecture to medical students and residents at Cambridge Hosptial.
1995-97 Lectured by invitation to more than 18 local conferences.
c. Advisory and supervisory responsibilities:
1980- Supervisor of residents, fellows, and post-doctoral students, Massachusetts Mental Health Center.
1985-87 Co-organizer with Alan Hobson, M.D., of New Psychiatry Seminar Series.
1985-88 Conference leader and organizer of Leadership in Public Psychiatry Seminar Series.
1985-90 Course developer and preceptor of Character Disorders Seminar for the residency training program, Massachusetts Mental Health Center.
1997- Reader at Harvard University for one student.
2. Regional, National or International
a. Invited presentations
1986- Lecture by invitation at 10-15 hospital medical grand rounds per year on a variety of above topics.
1986 Lecture by invitation at 20 conferences per year.
1988 Lectured by invitation to Collequium Internationale Neuro-Psychopharmacologicum, Munich, West Germany.
1989-90 Scientific exhibit: The effectiveness of serotonin active agents in the treatment of aggression presented at 3 conferences.
1991 Scientific exhibit: Buspirone therapy for maladaptive behavior in the developmentally disabled. Presented at the American Academy of Family
Physicians annual meeting, Washington, DC, 1991.
1991 Poster presented by Ratey J, Miller A, Parks A.: The use of buspar to treat aggressive and self-abusive behavior in the mentally retarded at the
World Federation of Societies of Biological Psychiatry, 5th World Congress, Florence, Italy.
1991 Abstract presented by Ratey J & Olivier B.: Anxiety and aggression: basic and clinical studies. to the Chairpersons, 5th World Congress of
Biological Psychiatry, Florence, Italy.
1991 Abstract presented by Ratey J.: Problems with measuring aggression in clinical research. at 5th World Congress of Biological Psychiatry, Florence, Italy.
1993 Poster presented by Ratey J, Leveroni C, Kilmer D, Gutheil C, Swartz B.: Effects of clozapine on aggressive inpatients. at the
American Psychiatric Association Meeting, San Francisco, CA.
2008- Frequent lectures about the effect of Exercise in the schools, in the elderly, and to treat mental illness and learning differences in Taiwan, Japan,
South Korea, Beijing, Copenhagen, Munich, London, Calgary, Toronto, Montreal, Edmonton
b. Professional Leadership Roles Related to Teaching:
1989 Chairperson and Presenter, APA Symposium, San Francisco, CA.
BIBLIOGRAPHY:
Original Reports
1. Schachter J, Lachin J, Kerr J, Wimberly F, Ratey J. Heart rate and blood pressure in black newborns and in white newborns. Pediatrics 1976; 58:283-286.
2. Ratey J, Mallinger A. The relationship between extra- and intracellular lithium concentration in human red blood cells: An in vitro study.
Br J Psychiat 1977; 131:59-62.
3. Ratey J, Cirualo D, Shader R. Lithium and marihuana. J Clin Psychopharm 1981; 1:32-33.
4. Ratey J, Morrill R, Oxenkrug G. Use of propranolol for provoked and unprovoked episodes of rage. Am J Psychiat 1983; 140:1356-57.
5. Ratey J, Salzman C. Recognizing and managing akathisia. Hosp Comm Psychiat 1984; 142:975-977.
6. Ratey J, Sorgi P, Polakoff S. Nadolol as a treatment for akathisia. Am J Psychiat 1985; 142:640-642.
7. Bemporad J, Ratey J. Intensive psychotherapy of former anorexic individuals. Amer J Psychotherapy 1985; 23:454-466.
8. Polakoff S, Sorgi P, Ratey J. The treatment of impulsive and aggressive behaviors with nadolol. J Clin Psychopharm 1986; 6:125-126.
9. Ratey J, Mikkelsen E, Smith GB, Upadhyaya A, Zuckerman HS,Martell D, Sorgi P, Polakoff S, Bemporad J. Betablockers in the severely and profoundly
mentally retarded. J ClinPsychopharm 1986; 6:103-7.
10. Bemporad J, Ratey, J. Loss and depression in young adults. J Am Acad Psychoanal 1986; 14:167-179.
11. Sorgi P, Ratey J, Polakoff S. Beta-adrenergic blockers for the control of chronically aggressive behaviors in patients with chronic schizophrenia.
Am J Psychiatry 1986; 143:775-776.
12. Ratey J, Mikkelsen E, Sorgi P, Polakoff S, Bick P, Zuckerman HS, Bemporad J. Autism: treatment of aggressive behavior. J Clin Psychopharm 1987; 7:35-41.
13. Ratey J, Bemporad J, Sorgi P, Polakoff S, Bick P, O'Driscoll G, Mikkelsen, E. Brief report: open trial effects of betablockers on speech and social behaviors in 8
autistic adults. J Autism and Dev Dis 1987; 17:439-446.
14. Bemporad J, Ratey J, O'Driscoll G, Daehler M. Anorexia, hysteria and the culture of self-denial. Psychiatry 1988; 51:96-102.
15. Ratey J, Sovner R, Mikkelsen E, Chmielinski H. Buspirone therapy of maladaptive behavior and anxiety in developmentally disabled persons.
J Clin Psychiatry 1989; 50:382-384.
16. Hallowell E, Bemporad, J, Ratey J. Depression in the transition to adult life. Adolescent Psychiatry 1989; 16.
17. Gold I, Ratey J, Lester D, Wolfson E, Chmielinski H. Developing a unit for mentally retarded-mentally ill patients on the grounds of a state hospital.
Hospital and Community Psychiatry 1989; 40:836-840.
18. Ratey J, Sorgi P, Lindem K, O'Driscoll G, Daehler M, Fletcher J, KadishW, Spruiell G, Polakoff S, Sands S, Richardson L. Nadolol to treat aggression and psychiatric
symptomology in chronic psychiatric inpatients: a double-blind placebo-controlled study. J Clin Psychiatry 1992; 53: 41-46.
19. Weinstein C, Seidmann L, Feldman J, Ratey J. Neurocognitive disorders in psychiatry: a case example of diagnostic and treatment dilemmas.
Psychiatry 1991; 54(1):65-75.
20. Ratey J, Greenberg M, Lindem K. A combination of treatments for Attention Deficit Hyperactivity Disorder in adults. J Nerv Ment Dis, 1991; 179(11): 699-701.
21. Ratey J, Sovner R, Parks A, Rogentine K. The use of buspirone in the treatment of aggression and anxiety in mentally retarded patients: a multiple-baseline,
placebo-controlled study. J Clin Psychiatry 1991; 52(4):159-161.
22. Ratey J, Komry V, Gaffar K, Leveroni C, Miller A. Low dose buspirone to treat agitation and maladaptive behavior in the brain injured: Two case reports
J Clin Psychopharmacol. 1992; 12(5): 362-364.
23. Colella R, Ratey J, Glaser A. Paramenstrual aggression in a mentally retarded adult ameliorated by buspirone. International Journal of Psychiatry in Medicine
1992; 22(4): 351-356.
24. Bemporad J, Beresin E, Ratey J, O'Driscill G, Lindem K, Herzog D. A Psychoanalytic Study of Eating Disorders: I. A Developmental Profile of 67 Index Cases.
J Amer Acad of Psychoanalysis. 1992; 20(4):509-531.
25. Bemporad J, O,Driscoll G, Beresin E, Ratey J, Lindem K, Herzog D. A Psychoanalytic Study of Eating Disorders: II. Intergroup and Intragroup Comparison.
J Amer Acad of Psychoanalysis. 1992; 20(4):533-541.
26. Ratey J, Greenberg M, Bemporad J, Lindem K. Unrecognized Attention-Deficit Hyperactivity Disorder in adults presenting for outpatient psychotherapy.
J Child and Adolescent Psychopharmacology. 1993; 2(4):267-275.
27. Ratey J, Leveroni C. The Treatment of Clinical Aggression: An integrative approach. Integrative Psychiatry 1993; 8(3):160-168.
28. Ratey J, Leveroni C, Kilmer D, Gutheil C, Swartz B. The effects of clozapine on severely aggressive in-patients on a Difficult to Manage Unit of a state hospital.
J Clin Psychiatry. 1993; 54(6):219-223.
29. Ratey J, Gordon A. The psychopharmacology of aggression. Psychopharm Bulletin. 1993; 29(1):65-73.
30. Ratey J, Hallowell E, Miller A. Psychosocial issues and psychotherapy in adults with Attention Deficit Disorder. Psychiatric Annals. (in press).
31. Sutton J, Ratey J. Beyond the Project: It’s About Time. Ann NY Acad Sci. May, 1998; 179-84.
32. Sattelmair JR, Ratey J. Physically Active Play and Cognition - An Academic Matter? American Journal of PLAY Winter 2009.
33. Ratey J, Loehr J., The Positive Impact of Physical Activity on Cognition During Adulthood: A Review of Underlying Mechanisms, Evidence,
and Recommendations. Neuroscience Review. Requested Submission
Proceedings of Meetings
1. Ratey J. Use of beta-blockers to treat autism. Presented at the APA Symposium, Washington DC, 1985.
2. Bemporad J, Ratey J, Hallowell E. Loss and depression in young adults. Presented at the Academy of Psychoanalysis, Dallas, 1985.
3. Ratey J. Beta-Blockers as an alternate to neuroleptics in aggression. Presented at the APA Symposium, Chicago, 1986.
4. Hallowell E, Bemporad, J, Ratey J. Depression in the transition to adult life. Presented at the Adolescent Psychiatry Annual Meeting, 1986.
5. Ratey J. The psychopharmacology of aggression. Presented at the Collegium Internationale Neuro-Psychopharmacologicum, Munich, Germany, 1988.
6. Ratey J. Beta-blockers as a primary treatment in the mentally retarded. Presented at the APA Symposium, San Fransisco, 1989.
7. Ratey J, Sorgi P, Lindem K, O'Driscoll G, Daehler M, Fletcher J, Kadish W, Spruiell, G, Polakoff S, Sands S, Richardson L, Knoedler D, Cole L, Arnold W. Nadolol
to treat aggression and psychiatric symptomatology in chronic psychiatric inpatients: a double-blind placebo controlled study. Presented at the New Research APA
National Meeting, San Fransisco,1989.
8. Ratey J, O'Driscoll G, Blumenkrantz M, Lindem K, Fletcher J. Nadolol to treat aggression in autistic adults. Presented at the New Research APA National Meeting,
San Fransisco, 1989.
9. Ratey J, Sovner R, Rogentine K. Buspirone for aggression in the mentally retarded. Presented at the New Research APA National Meeting, New York,1990.
10. Ratey J, Lindem K. Pindolol to treat aggression in the mentally retarded: a pilot study. Presented at the New Research APA National Meeting, New York, 1990.
11. Ratey J, Greenberg M, Bemporad J, Lindem K. Attention problems in adults. Presented at the APA Symposium, New York, 1990.
12. Ratey J, Gamser, D. The antelope and the reptile. Presented at the Society for the Study of Life Histories, Keystone, CO, 1990.
13. Ratey J, Grandin T, Rogentine K. Defense behavior and coping in an autistic savant. Presented at the Society for the Study of Life Histories, Keystone, CO, 1990.
14. Ratey J, Gutheil C. The measurement of aggressive behavior: reflections on the use of OAS and MOAS. Presented at the Clinical Aggression Research Group,
Washington, DC, 1990.
15. Ratey J. Problems with measuring aggression in clinical research. Abstract presented at the World Federation of Societies of Biological Psychiatry, 5th World
Congress, Florence, Italy, 1991, as appears in Supplement to Biological Psychiatry, 1991; 29(11S):210S.
16. Ratey J, Miller A. The masks and misdiagnosis of Attention Deficit Disorder in adults. Presented at the American Psychiatric Association Meeting (Symposium),
San Fransisco, CA, 1993.
Reviews and Educationally Relevent Publications
1. Schachter J, Ratey J, Wimberly F, Lachin J. Maternal weight gain and neonatal blood pressure level. Psychophysiology 1975; 2:233.
2. Ratey J, Sands S, O'Driscoll G. The phenomenology of recovery in a chronic schizophrenic. Psychiatry 1986; 49:277-289.
3. Sands S, Ratey J. The concept of noise. Psychiatry 1986; 49:290-7.
4. Bemporad J, Ratey J, O'Driscoll G. Autism and emotion: an ethological theory. Amer J Orthopsychiat 1987; 57:477-484.
5. Ratey J, O'Driscoll G, Daehler M, Sorgi P, Rosenfeld B. Beta-blockers in schizophrenia: a review of the literature. Submitted for publication. Abstract published in
DeLisi LE & Manolakes J (ed.): Abstracts of the V Biennial Winter Workshop on Schizophrenia. Schizophrenia Research:An International Multidisciplinary Journal
[Special Issue] 1990; 3(1):49.
6. Ratey J, Gutheil C. The measurement of aggressive behavior: reflections on the use of OAS and MOAS. J Neuropsychiatry and Clinical Neurosciences
1991; 3(2 Suppl):S57-S60.
7. Sorgi P, Ratey J, Knoedler D, Markert R, Reichman, M. Rating aggression in the clinical setting: a retrospective adaptation of the Overt Aggression Scale.
J Neuropsychiatry and Clincal Neurosciences 1991; 3(2):S52-S56.
8. Sorgi P, Ratey J, Knoedler D, Arnold W, Cole L. Depression during treatment with beta-blockers: results from a double-blind placebo-controlled
study. J Neuropsychiatry and Clinical Neurosciences 1992; 4(2):187-189.
9. Ratey J, Grandin T, Miller A. Defense behavior and coping in an autistic savant: The story of Temple Grandin, PhD. Psychiatry, 1992; 55:382-391.
10. Ratey J, Prough E. The effective use of beta-blockers for the treatment of mental disorders. Primary Psychiatry. 1995; 2(3):43-46.
11. Ratey J, Chandler H. Serenics: Therapeutic potential in aggression. CNS Drugs. 1995; 4(4):256-260.
12. Ratey J, Shah D. The neuroscientific manifestations of dyslexia. Primary Psychiatry. 1996; 4:22-24.
13. Ratey J, Prough E. The current status of beta-blockers in psychiatric practice. Directions in Psychiatry. 1996; 16(16):1-8.
Reviews:
1. Ratey J. Brain and Psyche. The Biology of the Unconscious. Jonathan Winson. New York: Anchor Press/Doubleday, 1985. Pp. xii - 300.
Queen's Quarterly, Autumn, 1986.
2. Ratey J. Beta blockers in the treatment of aggression. Harvard Medical School Mental Health Letter 1986; 3:8.
3. Ratey J. Overcoming autism: A first-person account: Comment. Harvard Medical School Mental Health Letter 1991; 7:9
Book Chapters
1. Ratey J, Gualtieri. (1991) Neuropsychiatry and Mental Retardation. In J. Ratey (ed), Mental Retardation: Developing Pharmacotherapies. Washington DC,
American Psychiatric Press.
2. Ratey J, Lindem K. (1991) B-Blockers as Primary Treatment for Aggression and Self-Injury in the Developmentally Disabled.. In J. Ratey (ed), Mental Retardation:
Developing Pharmacotherapies. Washington DC, American Psychiatric Press.
3. Hauser M, Ratey J. (1994) The Patient with Mental Retardation. In S.E. Hyman and G.E. Tesar (eds.), Manual of Psychiatric Emergencies. Boston, MA:
Little, Brown and Company.
4. Ratey J, MacNaughton K. (1995) Beta-Blocker Drug Interactions. In D. Ciraulo, R. Shader, D. Greenblatt, W. Creelman (eds). Drug Interactions in Psychiatry,
Second Edition. Baltimore, MD: Williams and Wilkins.
5. Ratey J, Middeldorp-Crispijn C, Leveroni C. (1994) The influence of attentional problems on the development of personality. In Ratey J (ed), The Neuropsychiatry of
Personality Disorders. Boston, MA: Scientific Publishing.
6. Fogel B, Ratey J. (1994) A Neuropsychiatric Approach to Personality and Behavior. In Ratey J (ed), The Neuropsychiatry of Personality Disorders. Boston, MA:
Blackwell Scientific Publishing.
7. Ratey J, Miller A, Nadeau K. (1994) Special Diagnostic and Treatment Considerations in Women with Attention Deficit Disorder. In K. Nadeau (ed), Attention Deficit
Disorder in Adults. Maryland: Chesapeake Press.
8. Ratey J, Hallowell E, Miller A. (1994) Relationship Issues for Adults with Attention Deficit Disorder: The biology of Intimacy. In K. Nadeau (ed), Attention Deficit
Disorder in Adults. Maryland: Chesapeake Press.
9. Ratey J, Dymek M. (1996) Neuropsychiatry of Mental Retardation and Cerebral Palsy. In B. Fogel and R. Schiffer (eds), Comprehensive Neuropsychiatry.
Baltimore, MD: Williams and Wilkins.
Books:
1. Ratey J (ed). Mental Retardation: Developing Pharmacotherapies. American Psychiatric Association Press, 1991.
2. Hallowell E & Ratey J. Driven to Distraction: Recognizing and Coping with Attention Deficit Disorder from Childhood through Adulthood. New York:
Pantheon Press, 1994.
3. Ratey J (ed). The Neuropsychiatry of Personality Disorders. London: Blackwell Science, 1994.
4. Hallowell E & Ratey J. Answers to Distraction. New York: Pantheon Books, 1995.
5. Ratey J & Johnson C. Shadow Syndromes: Recognizing and Coping with the Hidden Psychological Disorders That Can Influence Your Behavior and Silently
Determine the Course of Your Life. New York: Pantheon Books, 1997.
6. Ratey J. The User’s Guide to the Brain. New York: Pantheon Books, January 2001.
7. Hallowell E & Ratey J. Delivered From Distraction. New York: Ballantine Books, January 2005.
8. Ratey J. Spark: The Revolutionary New Science of Exercise and the Brain Little Brown, January 2008.
9. Ratey J. & Manning R. Go Wild: Free your mind and body from the afflictions of civilization Little Brown, June 2014
Contact John:
Site by SetYourSiteforGrowth
Copyright. All rights reserved.
